| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230155 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229991 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229827 Method for differentiating mesenchymal stem cells into neural cells |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229643 Solid oral formulation coated with hydroxypropyl methylcellulose; the polymer coating is free of polyethylene glycol |
| 06/12/2007 | US7229639 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229626 Administering Clostridial neurotoxin, wherein the Clostridial neurotoxin is administered to an intracranial site which is associated with the symptom of the neuropsychiatric disorder, thereby alleviating the symptom of the neuropsychiatric disorder |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2285445C 4-tetrahydropyridylpyrimidine derivative |
| 06/12/2007 | CA2284551C New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders |
| 06/12/2007 | CA2238410C Novel indole-2,3-dione-3-oxime derivatives |
| 06/12/2007 | CA2173418C Benzonitriles and benzofluorides |
| 06/12/2007 | CA2122340C Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 06/07/2007 | WO2007065167A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/07/2007 | WO2007064914A2 5-(arylsulfonyl)-pyrazolopiperidines |
| 06/07/2007 | WO2007064697A1 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| 06/07/2007 | WO2007064586A1 Methods of treating anxiety disorders |
| 06/07/2007 | WO2007064273A1 Phenyl urea derivatives |
| 06/07/2007 | WO2007064272A1 Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists |
| 06/07/2007 | WO2007064091A1 Pharmaceutical composition comprising p38 map kinase inhibitor for treating diseases caused by npc1 gene deficiency or self-renewal disorder of stem cells |
| 06/07/2007 | WO2007064010A1 Preventive/therapeutic agent for alzheimer's dementia |
| 06/07/2007 | WO2007063950A1 Long-wave fluorescent substance for diagnosis or treatment of conformation disease and use thereof |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063839A1 Cyclohexane derivative |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007063648A1 Agent for improving obesity conditions |
| 06/07/2007 | WO2007063418A2 Substituted indole compounds having nos inhibitory activity |
| 06/07/2007 | WO2007063391A2 Spirocyclic quinazoline derivatives as pde7 inhibitors |
| 06/07/2007 | WO2007063123A1 Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof |
| 06/07/2007 | WO2007063071A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors |
| 06/07/2007 | WO2007062998A1 3-amino-2-arylpropyl azaindoles and uses thereof |
| 06/07/2007 | WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | WO2007062862A2 Use of calmodulin inhibitors for the treatment of neurodegenerative disorders |
| 06/07/2007 | WO2007062594A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | WO2007057742A3 Novel piperazinone derivatives |
| 06/07/2007 | WO2007045432A9 Srf as a diagnostic and/or therapeutic target for diseases that are associated with neuronal abnormalities |
| 06/07/2007 | WO2007038676A3 Polymorphic forms of ladostigil tartrate |
| 06/07/2007 | WO2007031977A3 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/07/2007 | WO2007031326A3 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 06/07/2007 | WO2007030940A3 Methods of modulating neurotrophin-mediated activity |
| 06/07/2007 | WO2007028812A3 Selected cgrp antagonists method for production and use thereof as medicament |
| 06/07/2007 | WO2007028132A3 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 06/07/2007 | WO2007024846A3 Anit-il-23 antibiodies |
| 06/07/2007 | WO2007010281A3 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 06/07/2007 | WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 06/07/2007 | WO2006096404A3 Treatment of amyotrophic lateral sclerosis with norethindrone and anal0gues |
| 06/07/2007 | WO2006051413A8 Azabenoxazoles for the treatment of cns disorders |
| 06/07/2007 | WO2005065660A3 Ziprasidone formulations |
| 06/07/2007 | US20070129445 Therapeutic Agents |
| 06/07/2007 | US20070129440 Polypharmacophoric agents |
| 06/07/2007 | US20070129374 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129352 Novel crystal forms, methods for their preparation and method for preparation of olanzapine |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129317 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2637472A1 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 06/07/2007 | CA2632284A1 3-amino-2-arylpropyl azaindoles and uses thereof |
| 06/07/2007 | CA2632152A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | CA2631760A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/07/2007 | CA2631343A1 The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia |
| 06/07/2007 | CA2631195A1 Monoclonal antibodies against amyloid beta protein and uses thereof |
| 06/07/2007 | CA2630511A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/07/2007 | CA2629962A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | CA2624693A1 Pharmaceutical compositions comprising carboxyalkylsulfonic acids |
| 06/07/2007 | CA2605073A1 Substituted indole compounds having nos inhibitory activity |
| 06/06/2007 | EP1793005A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF |
| 06/06/2007 | EP1793001A2 Yeast screens for agents affecting protein folding |
| 06/06/2007 | EP1792997A1 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 06/06/2007 | EP1792991A1 Human CTLA-4 antibodies and their uses |
| 06/06/2007 | EP1792899A1 Process for production of optically active amine derivatives |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |